Volume 8, Issue 3 (Aug 2020)
Res Mol Med (RMM) 2020, 8(3): 103-106 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rahimi F, Talebi Bezmin Abadi A. Inhibitors of Angiotensin-converting Enzyme or Blockers of Angiotensin-2 Receptor in COVID-19 Patients with Comorbid Cardiovascular or Pulmonary Diseases. Res Mol Med (RMM) 2020; 8 (3) :103-106
URL: http://rmm.mazums.ac.ir/article-1-369-en.html
URL: http://rmm.mazums.ac.ir/article-1-369-en.html
1- Research School of Biology, The Australian National University, Canberra, Australia
2- Department of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran ,amin.talebi@modares.ac.ir
2- Department of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran ,
Abstract: (2944 Views)
N/A
Keywords: COVID-19, Cardiovascular disease, Chronic pulmonary disease, Gastrointestinal conditions, Pandemic, SARS-CoV-2
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
